Iron and cardiac ischemia: A natural, quasi-random experiment comparing eligible with disqualified blood donors (CME)

Transfusion

Volumn 53, Issue 6, 2013, Pages 1271-1279

  Germain, Marc ^a   Delage, Gilles ^a   Blais, Claudia ^a   Maunsell, Elizabeth ^a   Décary, Francine ^a   Grégoire, Yves ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGE; ARTICLE; BLOOD DONOR; CANADA; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HEALTH INSURANCE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PROBABILITY; SCREENING TEST;

ADOLESCENT; ADULT; BLOOD DONORS; CORONARY DISEASE; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; IRON; IRON OVERLOAD; ISCHEMIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PYRIDINES; QUEBEC; RISK FACTORS; YOUNG ADULT;

EID: 84878934163     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12081     Document Type: Article

References (36)

1. Sullivan JL,. The iron paradigm of ischemic heart disease. Am Heart J 1989; 117: 1177-1188.
2. de Valk B, Marx JJ,. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999; 159: 1542-1548.
3. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R,. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-811.
4. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ,. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89: 969-974.
5. Sempos CT, Looker AC, Gillum RF, Makuc DM,. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330: 1119-1124.
6. Araujo JA, Romano EL, Brito BE, Parthé V, Romano M, Bracho M, Montaño RF, Cardier J,. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995; 15: 1172-1180.
7. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F,. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-3307.
8. Lee TS, Shiao MS, Pan CC, Chau LY,. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999; 99: 1222-1229.
9. Danesh J, Appleby P,. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999; 99: 852-854.
10. Tuomainen TP, Salonen R, Nyyssönen K, Salonen JT,. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997; 314: 793-794.
11. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF,. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997; 78: 188-193.
12. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssönen K,. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio ischaemic heart disease risk factor study. Am J Epidemiol 1998; 148: 445-451.
13. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ,. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103: 52-57.
14. Meyers DG, Jensen KC, Menitove JE,. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42: 1135-1139.
15. Zheng H, Cable R, Spencer B, Votto N, Katz SD,. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 2005; 25: 1577-1583.
16. Atsma F, Veldhuizen I, Verbeek A, de, Kort W, de, Vegt F,. Healthy donor effect: its magnitude in health research among blood donors. Transfusion 2011; 51: 1820-1828.
17. Atsma F, de Vegt F,. The healthy donor effect: a matter of selection bias and confounding. Transfusion 2011; 51: 1883-1885.
18. Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW,. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007; 297: 603-610.
19. Hu FB,. The iron-heart hypothesis: search for the ironclad evidence. JAMA 2007; 297: 639-641.
20. Leitman SF, Klein HG, Melpolder JJ, Read EJ, Esteban JI, Leonard EM, Harvath L, Shih JW, Nealon R, Foy J, Darr F, Alter HJ,. Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. N Engl J Med 1989; 321: 917-924.
21. Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LL, Pau CP, Schreiber GB,. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1996; 36: 37-44.
22. Canadian Institute for Health Information. Coding Standards for Version 2009 ICD-10-CA and CCI, Revised September 2009 (Ottawa, Ont.: CIHI, 2009). ICD-10. [cited 2012 Dec 20]. Available from: URL: https://secure.cihi.ca/free- products/canadian-coding-standards-2009-rev-e.pdf
23. Canadian Classification of Health Interventions. CCICD-10. Volume Three-Tabular list. Canadian Institute for Health Information. 2012. [cited 2012 Dec 20]. Available from: URL: http://www.cihi.ca/CIHI-ext-portal/pdf/internet/ CCI-VOLUME-THREE-2012-EN
24. Dodd RY, Houlihan K, Lamberson HV,. The specificity of enzyme immunoassays for antibodies to human immunodeficiency virus: impact on record and donor management. Transfusion 1993; 33: 693.
25. Bouillon M, Aubin E, Roberge C, Bazin R, Lemieux R,. Reduced frequency of blood donors with false-positive HIV-1 and -2 antibody EIA reactivity after elution of low-affinity nonspecific natural antibodies. Transfusion 2002; 42: 1046-1052.
26. Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, Kleinman SH, Busch MP,; Retrovirus Epidemiology Donor Study. Impact of changes in viral marker screening assays. Transfusion 2003; 43: 202-214.
27. Stearns FM, Ashwin L, Brodsky JP, Krysztof DE, Stramer SL,. Elevated repeat reactive rates with the Abbott HIV O Plus blood donor screening assay [abstract]. Transfusion 2010; 50 (S): 4A-5A.
28. US Department of Health and Human Services. Guidance for industry. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry. Washington, DC: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. May 2010. [cited 2012 Dec 20]. Available from: URL: http://www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ UCM210270.pdf
29. Ownby HE, Korelitz JJ, Busch MP, Williams AE, Kleinman SH, Gilcher RO, Nourjah P,. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study. Transfusion 1997; 37: 199-205.
30. Pilote L, Lavoie F, Ho V, Eisenberg MJ,. Changes in the treatment and outcomes of acute myocardial infarction in Quebec,1988-1995. CMAJ 2000; 163: 31-36.
31. Loslier J, Vanasse A, Niyonsenga T, Courteau J, Orzanco G, Hemiari A,. Myocardial infarction in Québec rural and urban populations between 1995 and 1997. Can J Rural Med 2007; 12: 95-102.
32. Lambert L, Blais C, Hamel D, Brown K, Rinfret S, Cartier R, Giguère M, Carroll C, Beauchamp C, Bogaty P,. Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data? Can J Cardiol 2012; 28: 162-168.
33. Auer R, Bauer DC, Marques-Vidal P, Butler J, Min LJ, Cornuz J, Satterfield S, Newman AB, Vittinghoff E, Rodondi N,; Health ABC Study. Association of major and minor ECG abnormalities with coronary heart disease events. JAMA 2012; 307: 1497-1505.
34. St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B,. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005; 25: 553-559.
35. Eason S, Goudar S, Centilli J, Sayers M,. Experience with routine total nonfasting blood cholesterol screening of volunteer blood and component donors. Transfusion 2011; 51: 731-736.
36. Hemilä H, Paunio M,. Blood donation, body iron stores, and risk of myocardial infarction. Confidence intervals and possible selection bias call study results into question. BMJ 1997; 314: 1830-1831.